Small caps, big tailwinds
Nick Sladen, from LSN Capital Partners, provides his perspective on the current market trends.
5 small stocks with big catalysts | Livewire
In this episode of Buy Hold Sell, LSN Capital's Nick Sladen discusses five stocks with possible share price-moving catalysts.
2 undiscovered stocks | Livewire
2 undiscovered stocks (and how to analyse under-the-radar companies)
3 under-the-radar stocks | Livewire
Buy Hold Sell: 3 under-the-radar stocks (and 2 overcrowded darlings)
The good and bad from reporting season Feb 24
Nick Sladen from LSN Capital Partners offers insights on the market trends following the Australian reporting season.
LSN Capital reaches 2-year milestone | Q&A with founders
It’s been two years since Nick Sladen and Nick Leitl launched the LSN Emerging Companies Fund. What motivated them to launch the business, and what have been the successes and learnings? Read more
Three small caps with earnings growth
Nick Sladen of LSN Capital Partners shares his take on the future growth prospects of different sectors during this reporting season. Watch video
Nick Sladen talks Equity Trustees on Talk Ya Book
Nick Sladen discusses the bullish case for Equity Trustees with Chris Judd on Talk Ya Book.
Why small-caps look very attractive (and 2 ASX stocks for 2024)
This part of the market looks increasingly attractive for several reasons.
7 growth stocks for the next 10 years
LSN Capital Partners' Nick Sladen and Elvest's Adrian Ezquerro share their tips for finding the best growth opportunities
Buy Hold Sell: 3 stocks with high ROEs (and 2 fundie favourites)
LSN Capital's Nick Sladen and Elvest's Adrian Ezquerro analyse five of the ASX's most efficiently growing stocks
The bullish thesis for ASX-listed PSQ
Nick shares his bullish thesis for Pacific Smiles, why he likes their growth strategy, how quickly he thinks they can grow and what comes next for the ASX listed dental business.
Top three healthcare picks | AusBiz
Speaking with Nadine Blaney from ausbiz about small caps across the healthcare sector.
Three ASX stocks to play healthcare's return to normalisation
Against a challenging economic backdrop, the Healthcare sector is well placed to deliver earnings growth in the coming years.
Who will benefit from Australia's housing shortage?
Companies that successfully navigate the next 3-6 months will have an excellent runway in the years ahead.
Small cap reporting season so far | AusBiz
Nick Sladen of LSN Capital joined to chat about the small cap highlights of reporting season, in addition to travel stocks
15 Investment themes for your radar in 2023
LSN Capital Partners' Nick Sladen and 14 other fundies describe the investment themes they're keeping an eye on.
No bears here: The 6 bulls you’ll met in 2023
Six of Melbourne's finest market experts believe it’s time to ignore the market noise and look to greener pastures ahead
Outlook for small caps in 2023 | AusBiz
2022 is drawing to a close so we got some views on the outlook for small caps in 2023. Nick Sladen from LSN Capital Partners joined us